KLAUDTARA Trademark

Trademark Overview

On Wednesday, March 15, 2023, a trademark application was filed for KLAUDTARA with the United States Patent and Trademark Office. The USPTO has given the KLAUDTARA trademark a serial number of 97840183. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, October 15, 2024. This trademark is owned by Astellas Pharma Inc.. The KLAUDTARA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
klaudtara

General Information

Serial Number97840183
Word MarkKLAUDTARA
Filing DateWednesday, March 15, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 20, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP
Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP

Trademark Events

Event DateEvent Description
Saturday, March 18, 2023NEW APPLICATION ENTERED
Monday, March 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 10, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, July 28, 2023ASSIGNED TO EXAMINER
Thursday, August 10, 2023NON-FINAL ACTION WRITTEN
Thursday, August 10, 2023NON-FINAL ACTION E-MAILED
Thursday, August 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 6, 2024ASSIGNED TO LIE
Tuesday, February 6, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, February 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 7, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 9, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, July 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 9, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, October 15, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 15, 2024SOU EXTENSION 1 FILED
Tuesday, October 15, 2024SOU EXTENSION 1 GRANTED
Tuesday, May 7, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

klaudtara cancer treatment preparations pharmaceutical